Skip to main content
Top
Published in: Journal of Gastroenterology 9/2013

01-09-2013 | Original Article—Liver, Pancreas, and Biliary Tract

Extrahepatic bile duct measurement by using transabdominal ultrasound in Japanese adults: multi-center prospective study

Authors: Takao Itoi, Terumi Kamisawa, Hideki Fujii, Kazuo Inui, Hiroyuki Maguchi, Yoshinori Hamada, Toshiaki Nakano, Hisami Ando, Tsugumichi Koshinaga, Keiko Shibagaki, Taminori Obayashi, Yasuhiko Miyazawa

Published in: Journal of Gastroenterology | Issue 9/2013

Login to get access

Abstract

Background

In adults, less than 10-mm bile duct has idiomatically been recognized as “non-dilated bile duct” though there was no obvious evidence. The aim of this study was to prospectively examine the maximum inner diameter of extrahepatic bile duct (MDEBD) in consecutive adults.

Methods

Transabdominal ultrasound (US) was performed to measure the MDEBD of 8840 cases (4420 male) in five institutions. The frequency of ultrasound probe ranged from 3.5 to 5 MHz.

Results

The mean diameter of MDEBD was 4.5 ± 1.4 mm (range 1–14 mm). The relationship between the MDEBD and age was shown as follows: MDEBD = 2.83 + 0.03 × age. Multiple regression analysis was analyzed between 6 groups and significant α level is 0.008 in this analysis. In all age groups but 20s and 30s, there was statistically significant MDEBD among each age group (p < 0.0001). Mean, mode value and median MDEBD is increasing according to the age as follows: 20s: 3.9 ± 1.0 mm, 30s: 3.9 ± 1.2 mm, 40s: 4.3 ± 1.2 mm, 50s: 4.6 ± 1.3 mm, 60s: 4.9 ± 1.4 mm, >70s: 5.3 ± 1.6 mm.

Conclusion

The present study revealed that MDEBD positively correlates with age. Therefore, when we examine the presence of dilation of the bile duct, our calculating formula appears to be suitable for accurate evaluation.
Literature
1.
go back to reference Babbit DP. Congenital choledochal cyst: new etiological concept based on anomalous relationships of the common bile duct and pancreatic bulb. Ann Radiol. 1969;12:231–40. Babbit DP. Congenital choledochal cyst: new etiological concept based on anomalous relationships of the common bile duct and pancreatic bulb. Ann Radiol. 1969;12:231–40.
2.
go back to reference Kamisawa T, Ando H, Suyama M, Working Committee of Clinical Practice Guidelines for Pancreaticobiliary Maljunction, et al. Japanese clinical practice guidelines for pancreaticobiliary maljunction. J Gastroenterol. 2012;47:731–59.PubMedCrossRef Kamisawa T, Ando H, Suyama M, Working Committee of Clinical Practice Guidelines for Pancreaticobiliary Maljunction, et al. Japanese clinical practice guidelines for pancreaticobiliary maljunction. J Gastroenterol. 2012;47:731–59.PubMedCrossRef
3.
go back to reference Tsuchida A, Itoi T, Aoki T, Koyanagi Y. Carcinogenetic process in gallbladder mucosa with pancreaticobiliary maljunction (Review). Oncol Rep. 2003;10:1693–9.PubMed Tsuchida A, Itoi T, Aoki T, Koyanagi Y. Carcinogenetic process in gallbladder mucosa with pancreaticobiliary maljunction (Review). Oncol Rep. 2003;10:1693–9.PubMed
4.
go back to reference Tashiro S, Imaizumi T, Ohkawa H, et al. Overall report on the registration study of the Japanese study group on pancreaticobiliary maljunction for the past 10 years. In: Koyanagi Y, Aoki T, editors. Pancreaticobiliary maljunction. Tokyo: Igaku Tosho; 2002. p. 401–10. Tashiro S, Imaizumi T, Ohkawa H, et al. Overall report on the registration study of the Japanese study group on pancreaticobiliary maljunction for the past 10 years. In: Koyanagi Y, Aoki T, editors. Pancreaticobiliary maljunction. Tokyo: Igaku Tosho; 2002. p. 401–10.
5.
go back to reference Aoki T, Tsuchida A, Kasuya K, et al. Is preventive resection of the extrahepatic bile duct necessary in cases of pancreaticobiliary maljunction without dilation of the bile duct? Jpn J Clin Oncol. 2001;31:107–11.PubMedCrossRef Aoki T, Tsuchida A, Kasuya K, et al. Is preventive resection of the extrahepatic bile duct necessary in cases of pancreaticobiliary maljunction without dilation of the bile duct? Jpn J Clin Oncol. 2001;31:107–11.PubMedCrossRef
6.
go back to reference Ando H, Ito T, Nagayo M, et al. Pancreaticobiliary maljunction without choledochal cysts in infants and children: clinical features and surgical therapy. J Pediatr Surg. 1995;30:1658–62.PubMedCrossRef Ando H, Ito T, Nagayo M, et al. Pancreaticobiliary maljunction without choledochal cysts in infants and children: clinical features and surgical therapy. J Pediatr Surg. 1995;30:1658–62.PubMedCrossRef
7.
go back to reference Miyano T, Ando K, Yamataka A, et al. Pancreaticobiliary maljunction associated with nondilatation or minimal dilatation of the common bile duct in children: diagnosis and treatment. Eur J Pediatr Surg. 1996;6:334–7.PubMedCrossRef Miyano T, Ando K, Yamataka A, et al. Pancreaticobiliary maljunction associated with nondilatation or minimal dilatation of the common bile duct in children: diagnosis and treatment. Eur J Pediatr Surg. 1996;6:334–7.PubMedCrossRef
8.
go back to reference Perret RS, Sloop GD, Borne JA. Common bile duct measurements in an elderly population. J Ultrasound Med. 2000;19:727–30.PubMed Perret RS, Sloop GD, Borne JA. Common bile duct measurements in an elderly population. J Ultrasound Med. 2000;19:727–30.PubMed
9.
go back to reference Admassie D. Ultrasound assessment of common bile duct diameter in Tikur Anbessa Hospital, Addis Ababa Ethiopia. Ethiop Med J. 2008;46:391–5.PubMed Admassie D. Ultrasound assessment of common bile duct diameter in Tikur Anbessa Hospital, Addis Ababa Ethiopia. Ethiop Med J. 2008;46:391–5.PubMed
10.
go back to reference Hamada Y, Kamisawa T, Ando H, et al. Definition of biliary dilatation based on standard diameter of the bile duct in children. Tan to Sui. 2010;31:1269–72 (in Japanese). Hamada Y, Kamisawa T, Ando H, et al. Definition of biliary dilatation based on standard diameter of the bile duct in children. Tan to Sui. 2010;31:1269–72 (in Japanese).
Metadata
Title
Extrahepatic bile duct measurement by using transabdominal ultrasound in Japanese adults: multi-center prospective study
Authors
Takao Itoi
Terumi Kamisawa
Hideki Fujii
Kazuo Inui
Hiroyuki Maguchi
Yoshinori Hamada
Toshiaki Nakano
Hisami Ando
Tsugumichi Koshinaga
Keiko Shibagaki
Taminori Obayashi
Yasuhiko Miyazawa
Publication date
01-09-2013
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 9/2013
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-012-0702-0

Other articles of this Issue 9/2013

Journal of Gastroenterology 9/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.